Toggle navigation
Home
Search
Services
Blog
Contact
About
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W.
Covance Laboratories, Inc., Vienna, VA, United States
Search 19 grants from Daniel Dalgard
Search grants from Covance Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
The Infant Development and the Environmental Study (TIDES)
Role of Orexin in Morphine Dependence and Withdrawal
Comprehensive Teledermatology System
The Biosynthesis of L-Type Channel Subunits
Recently added grants:
Heat-shock protein 90 modulates goblet cell metaplasia in human airway epithelia
Role of ANO1 Channels and Its Regulation by PIP2 in EC-Coupling in Pulmonary Artery Myocytes
Acoustic System for Diagnosis of Pneumonia and Pneumothorax using Transfer Function Analysis
VITAL Start (Video-intervention to Inspire Treatment Adherence for Life): Brief facility based video intervention to improve retention and adherence to ART among pregnant and breastfeeding women
Dose Determination Trial for Implementing Evidence-Basedbehavioral Interventions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM025601-009
Application #
3609868
Study Section
Project Start
1981-11-01
Project End
1984-10-31
Budget Start
1985-02-20
Budget End
1984-10-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Covance Laboratories, Inc.
Department
Type
DUNS #
City
Vienna
State
VA
Country
United States
Zip Code
22182
Related projects
NIH 1986
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
NIH 1985
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
Comments
Be the first to comment on Daniel Dalgard's grant